It is a continual challenge trying to improve the quality of prescribing while concurrently
trying to address increasing pharmaceutical development, utilization and expenditure …

Background The proportion of total healthcare expenditures spent on drugs has continued to
grow in countries of all income categories. Policy‐makers are under pressure to control …

Sweden's pharmaceutical expenditure has increased during the last decades. On 1 October
2002 mandatory generic substitution was introduced in Sweden with the purpose to reduce …

This paper examines aspects of the policy environment and market characteristics of the
Swedish pharmaceutical sector, assesses the degree to which Sweden has achieved …

With an aging population and increased prevalence of chronic diseases, such as obesity
and diabetes mellitus, drug reforms are needed across Europe to ensure the continued …

Physicians' decisions whether or not to veto generic substitution were analyzed using a
sample of 350,000 pharmaceutical prescriptions from the county of Västerbotten, Sweden …

To contain pharmaceutical spending, drug budgets have been introduced across health
systems. Apart from analyzing whether drug budgets fulfill their overall goal of reducing …

This study exploits policy reforms in Swedish primary care to examine the effect of pay-for-
performance (P4P) on compliance with hypertension drug guidelines among public and …

A vast majority of the EU countries are witnessing a rise in the share of public
pharmaceutical spending in the total drugs expenditure. This urges governments to adopt …

Objectives: The current study aims to analyze, from a historical perspective, the regulatory
framework of prices and reimbursement in Bulgaria with emphasis on the introduction of …